France· FR:60153239
ALFALASTIN 33,33 mg/mL, poudre et solvant pour solution injectable
A medicinal product containing alpha-1 antitrypsine humaine, registered in France by LFB-BIOMEDICAMENTS.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ALPHA-1 ANTITRYPSINE HUMAINE
- Manufacturer
- LFB-BIOMEDICAMENTS
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip1334009566118981 flacon(s) en verre - 1 flacon(s) en verre de 100 mL avec capsules de protection composé avec seringue(s) de 30 mL avec 2 aiguille(s) filtre(s) et de deux prises d’air
- cip1334009579376141 flacon(s) en verre - 1 flacon(s) en verre de 120 mL avec dispositif(s) de transfert avec filtre(s) avec matériel(s) de perfusion muni d'un filtre
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Alpha-1 antitrypsine humaine in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandProlastinaGrifols Deutschland GmbH
- CzechiaPROLASTINAGrifols Deutschland GmbH, Frankfurt
- SwedenProlastina 1000 mg Pulver och vätska till infusionsvätska, lösningGrifols Deutschland GmbH
- NorwayProlastinaGrifols Deutschland GmbH
- PolandRespreezaCSL Behring GmbH
- IrelandProlastin 4000 mg, powder and solvent for solution for infusionGrifols Deutschland GmbH
- IcelandRespreezaCSL Behring GmbH*
- United StatesGLASSIATakeda Pharmaceuticals America, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Prolastin
- Belgium · Pulmolast
- Cyprus · Prolastina
- Czechia · Prolastina
- Germany · Prolastin
- Denmark · Prolastina
- Spain · Prolasplan, Prolastina
- Finland · Prolastina
- Greece · Prolastin
- Croatia · Prolastina
- Ireland · Prolastin
- Iceland · Respreeza
- Italy · Plitalfa, Prolastin
- Liechtenstein · Respreeza
- Netherlands · Prolastin
- Norway · Prolastina, Respreeza
- Poland · Prolastin, Prolastin, 4000 Mg
- Portugal · Prolastin
- Sweden · Prolastina
- Slovakia · Prolastina
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/90ebed1b-8d79-4e50-b28f-a9821be9a1fd GET /v1/drugs/90ebed1b-8d79-4e50-b28f-a9821be9a1fd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60153239",
"date_amm": "2005-07-08",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "ALPHA-1 ANTITRYPSINE HUMAINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about alpha-1 antitrypsine humaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.